본문으로 건너뛰기
← 뒤로

Model-based evaluation of colorectal cancer screening effectiveness: three rounds of multitarget stool DNA testing versus one colonoscopy.

2/5 보강
Journal of medical economics 📖 저널 OA 43.5% 2021: 0/1 OA 2022: 0/1 OA 2023: 0/2 OA 2024: 1/2 OA 2025: 1/30 OA 2026: 25/26 OA 2021~2026 2026 Vol.29(1) p. 986-993 OA Colorectal Cancer Screening and Dete
Retraction 확인
출처
PubMed DOI OpenAlex 마지막 보강 2026-04-28
OpenAlex 토픽 · Colorectal Cancer Screening and Detection Genetic factors in colorectal cancer Colorectal Cancer Surgical Treatments

Dore M, Ebner DW, Vahdat V, Estes C, Ozbay AB, Foster V

📖 무료 전문 🔓 OA PDF oa
📝 환자 설명용 한 줄

[BACKGROUND] Several colorectal cancer (CRC) screening modalities are guideline-recommended in the United States but differ in screening interval and real-world adherence.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Michael Dore, Derek W. Ebner, et al. (2026). Model-based evaluation of colorectal cancer screening effectiveness: three rounds of multitarget stool DNA testing versus one colonoscopy.. Journal of medical economics, 29(1), 986-993. https://doi.org/10.1080/13696998.2026.2645491
MLA Michael Dore, et al.. "Model-based evaluation of colorectal cancer screening effectiveness: three rounds of multitarget stool DNA testing versus one colonoscopy.." Journal of medical economics, vol. 29, no. 1, 2026, pp. 986-993.
PMID 41879223 ↗

Abstract

[BACKGROUND] Several colorectal cancer (CRC) screening modalities are guideline-recommended in the United States but differ in screening interval and real-world adherence. Accordingly, single-round test performance may not reflect cumulative effectiveness over time. This study compared the 10-year longitudinal outcomes of two CRC screening strategies-triennial next-generation multitarget stool DNA testing (ng mt-sDNA) and decennial screening colonoscopy.

[METHODS] The validated, microsimulation-based Colorectal Cancer and Adenoma Incidence and Mortality (CRC-AIM) model was used to estimate 10-year cumulative outcomes for two guideline-recommended screening strategies: triennial ng mt-sDNA and decennial colonoscopy. Model inputs included test performance and real-world adherence. Outcomes included CRC and precancerous lesions detected, CRC mortality reductions, and life-years gained (LYG). Sensitivity analyses examined the effects of varying screening adherence and follow-up colonoscopy adherence.

[RESULTS] Over 10 years per 1,000 individuals offered screening, ng mt-sDNA detected 13% more precancerous lesions and 11% more CRC cases than colonoscopy, with a greater proportion of CRCs identified through screening rather than symptomatic detection. ng mt-sDNA achieved greater CRC mortality reduction (33% vs 20%) and 62% more life-years gained, with consistent findings across sensitivity analyses.

[CONCLUSIONS] With real-world adherence, screening with triennial ng mt-sDNA demonstrates superior cumulative effectiveness compared with decennial colonoscopy, driven by higher adherence and favorable longitudinal performance. These findings support expanded use of noninvasive stool-based screening to reduce CRC mortality and alleviate colonoscopy capacity constraints. Broader adoption of ng mt-sDNA may enhance population-level CRC prevention by increasing participation and improving early detection.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (1)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🔓 OA PDF 열기